Bone Diseases  >>  Cubicin (daptomycin)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cubicin (daptomycin) / Merck (MSD)
MK-3009-006, NCT01922011 / 2013-000864-28: Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO)

Completed
3
149
NA
Daptomycin, Vancomycin (or equivalent), Nafcillin (or equivalent)
Cubist Pharmaceuticals LLC
Acute Hematogenous Osteomyelitis
06/16
12/16

Download Options